Bonos de GSKD
A continuación, encontrará la lista de bonos de corporativos GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs. Los inversores suelen optar por los bonos de empresa debido a su mayor estabilidad en tiempos de volatilidad del mercado. Estudie los precios, los rendimientos y otras estadísticas para encontrar una inversión fiable.
Símbolo | YTM % | Volumen | Precio % | Cupón % | Fecha de vencimiento | Imp. pendiente | Valor nominal | Imp. mín. denom. | Emisor |
|---|---|---|---|---|---|---|---|---|---|
| GGSK.GJGlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038 | — | 436 K | 113,34% | 6,38% | 2038-05-15 | 2,75 B USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| GGSK6023693GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035 | — | 1,41 M | 101,36% | 4,88% | 2035-04-15 | 750 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| GGSK6023695GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030 | — | 418 K | 101,74% | 4,50% | 2030-04-15 | 850 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| GGSK6023691GlaxoSmithKline Capital Plc 4.315% 12-MAR-2027 | — | 40 K | 100,72% | 4,32% | 2027-03-12 | 400 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital Plc |
| GGSK6023692GlaxoSmithKline Capital Plc FRN 12-MAR-2027 | — | 1,69 M | 100,30% | 4,86% | 2027-03-12 | 600 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital Plc |
| GGSK3981911GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043 | — | 250 K | 88,04% | 4,20% | 2043-03-18 | 500 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| 883GIGlaxoSmithKline Capital Plc 5.25% 10-APR-2042 | — | 0 | 94,53% | 5,25% | 2042-04-10 | 477,82 M GBP | 1.000,00 GBP | 50.000,00 GBP | GlaxoSmithKline Capital Plc |
| 117RIGlaxoSmithKline Capital Plc 4.25% 18-DEC-2045 | — | 8,46 K | 82,51% | 4,25% | 2045-12-18 | 370,79 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| AAQ72GlaxoSmithKline Capital Plc 0.883% 21-SEP-2028 | — | — | — | 0,88% | 2028-09-21 | 42,5 B JPY | 100.000.000,00 JPY | 100.000.000,00 JPY | GlaxoSmithKline Capital Plc |
| AAG99GlaxoSmithKline Capital Plc 5.25% 19-DEC-2033 | — | 0 | 103,48% | 5,25% | 2033-12-19 | 574,17 M GBP | 1.000,00 GBP | 1.000,00 GBP | GlaxoSmithKline Capital Plc |
| 117RNGlaxoSmithKline Capital Plc 3.375% 20-DEC-2027 | — | 0 | 112,19% | 3,38% | 2027-12-20 | 307,77 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| 772WIGlaxoSmithKline Capital, Inc. 5.375% 15-APR-2034 | — | 0 | 105,28% | 5,38% | 2034-04-15 | 500 M USD | 1.000,00 USD | 1.000,00 USD | GlaxoSmithKline Capital, Inc. |
| 771ZCGlaxoSmithKline Capital Plc 6.375% 09-MAR-2039 | — | 0 | 107,50% | 6,38% | 2039-03-09 | 631,3 M GBP | 1.000,00 GBP | 50.000,00 GBP | GlaxoSmithKline Capital Plc |
| GGX5BGlaxoSmithKline Capital Plc 1.0% 12-SEP-2026 | — | 0 | 98,81% | 1,00% | 2026-09-12 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| XXS255381768GSK Capital BV 3.0% 28-NOV-2027 | — | 0 | 101,21% | 3,00% | 2027-11-28 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| XXS255381776GSK Capital BV 3.125% 28-NOV-2032 | — | 0 | 99,80% | 3,13% | 2032-11-28 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| UUS377372AN7GlaxoSmithKline Capital, Inc. 3.875% 15-MAY-2028 | — | 0 | 99,86% | 3,88% | 2028-05-15 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| XXS168152035GlaxoSmithKline Capital Plc 1.375% 12-SEP-2029 | — | 0 | 95,24% | 1,38% | 2029-09-12 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| XXS217060907GlaxoSmithKline Capital Plc 1.625% 12-MAY-2035 | — | 0 | 73,10% | 1,63% | 2035-05-12 | 750 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| XXS293369143GSK Capital BV 2.875% 19-NOV-2031 | — | 0 | 99,16% | 2,88% | 2031-11-19 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| XXS182282812GlaxoSmithKline Capital Plc 1.25% 21-MAY-2026 | — | 0 | 99,39% | 1,25% | 2026-05-21 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| XXS182282979GlaxoSmithKline Capital Plc 1.75% 21-MAY-2030 | — | 0 | 95,29% | 1,75% | 2030-05-21 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| XXS293369275GSK Capital BV 3.25% 19-NOV-2036 | — | 0 | 97,42% | 3,25% | 2036-11-19 | 600 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| UUS377373AH8GlaxoSmithKline Capital Plc 3.375% 01-JUN-2029 | — | 0 | 97,81% | 3,38% | 2029-06-01 | 1 B USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital Plc |
| XXS217060184GlaxoSmithKline Capital Plc 1.25% 12-OCT-2028 | — | 0 | 91,78% | 1,25% | 2028-10-12 | 750 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |